Urothelial carcinoma of the prostate. 1985

R Goebbels, and L Amberger, and N Wernert, and G Dhom

Urothelial carcinoma is a rare type of prostatic carcinoma which as a rule bears an unfavourable prognosis. In our material it comprises 4.5% of all prostatic carcinomas. It can occur isolated in the prostate as well as in connection with a urothelial carcinoma of the urinary bladder, which may have directly infiltrated the prostate. Almost one-third of our cases are combined with an ordinary carcinoma of the prostate. The majority of pure urothelial carcinomas, with or without bladder involvement, are found in stages 0-B (59 of 68 cases). When combined with an ordinary prostatic carcinoma, most urothelial carcinomas (20 of 29 cases) are present in stages C and D. Independent of bladder involvement, 24 urothelial carcinomas are grade II and 86 grade III tumours. Survival times range from 12 to 84 months (average 34.8 months) in grade II and from 1 to 103 months (average 29.5 months) in grade III carcinomas. Problems in differential diagnosis arise when urothelial carcinoma has to be distinguished from solid or, rarely, cribriform prostatic carcinoma. Diagnostic criteria for urothelial carcinoma are compact formations without stroma being sharply delineated from stroma, extensive ductal growth pattern with necroses of comedo type, high mitotic rates and perifocal inflammation.

UI MeSH Term Description Entries
D008297 Male Males
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009378 Neoplasms, Multiple Primary Two or more abnormal growths of tissue occurring simultaneously and presumed to be of separate origin. The neoplasms may be histologically the same or different, and may be found in the same or different sites. Neoplasms, Synchronous,Neoplasms, Synchronous Multiple Primary,Multiple Primary Neoplasms,Multiple Primary Neoplasms, Synchronous,Synchronous Multiple Primary Neoplasms,Synchronous Neoplasms,Multiple Primary Neoplasm,Neoplasm, Multiple Primary,Neoplasm, Synchronous,Primary Neoplasm, Multiple,Primary Neoplasms, Multiple,Synchronous Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

R Goebbels, and L Amberger, and N Wernert, and G Dhom
January 2007, Urology,
R Goebbels, and L Amberger, and N Wernert, and G Dhom
March 1977, Der Urologe. Ausg. A,
R Goebbels, and L Amberger, and N Wernert, and G Dhom
December 2006, Hinyokika kiyo. Acta urologica Japonica,
R Goebbels, and L Amberger, and N Wernert, and G Dhom
July 2010, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
R Goebbels, and L Amberger, and N Wernert, and G Dhom
August 2007, The American journal of surgical pathology,
R Goebbels, and L Amberger, and N Wernert, and G Dhom
January 1988, Journal d'urologie,
R Goebbels, and L Amberger, and N Wernert, and G Dhom
January 2019, Medicine,
R Goebbels, and L Amberger, and N Wernert, and G Dhom
September 2016, Journal of pathology and translational medicine,
R Goebbels, and L Amberger, and N Wernert, and G Dhom
March 2007, Expert review of anticancer therapy,
R Goebbels, and L Amberger, and N Wernert, and G Dhom
July 2016, Urology case reports,
Copied contents to your clipboard!